Lifson A R, Rutherford G W, Jaffe H W
San Francisco Department of Public Health, California 94103.
J Infect Dis. 1988 Dec;158(6):1360-7. doi: 10.1093/infdis/158.6.1360.
Although much is known about the natural history of HIV infection, many issues remain unresolved and require additional study. At least four major questions require further investigation. (1) Current data suggest that most HIV-infected persons will eventually develop AIDS. The proportion of all infected persons who will eventually develop AIDS, as well as the average and maximum incubation periods, have not yet been conclusively defined. (2) Certain clinical signs (such as oral candidiasis) or laboratory test results (such as a depressed T4 count) may indicate a poorer prognosis. However, the predictive value of such indicators for a specific patient and in an individual situation varies. Combinations of clinical and laboratory data may help refine estimates of the likelihood of developing AIDS or other HIV-related diseases. (3) Why some HIV-infected persons develop disease and others do not is not completely understood. The role of cofactors for disease progression needs additional investigation. There may be no one universal cofactor for progression but, rather, various agents that cause immune stimulation and reactivation of latent HIV. Therefore, exposure to a variety of infectious or environmental agents (such as through sexually transmitted diseases or injection of iv drugs) may accelerate progression to disease in HIV-infected persons. (4) It is not established whether antiviral agents will prevent or reduce the likelihood of disease progression in asymptomatic HIV-infected persons. If beneficial, should they be given to all HIV-infected persons or only to those whose clinical and laboratory evaluation suggests an increased likelihood of progression? Given these uncertainties, how should the physician or other health care worker evaluate, treat, and counsel the HIV-infected patient? Such patients should receive a comprehensive medical evaluation for both diagnostic and staging purposes; the details of such an evaluation are beyond the scope of this review and have been well described. A few brief points, however, should be emphasized.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管人们对HIV感染的自然史已了解很多,但仍有许多问题尚未解决,需要进一步研究。至少有四个主要问题需要深入调查。(1)目前的数据表明,大多数HIV感染者最终会发展为艾滋病。所有最终会发展为艾滋病的感染者比例,以及平均和最长潜伏期,尚未得到确切界定。(2)某些临床体征(如口腔念珠菌病)或实验室检查结果(如T4细胞计数降低)可能预示预后较差。然而,这些指标在特定患者和个体情况下的预测价值各不相同。临床和实验室数据的综合可能有助于更精确地估计发展为艾滋病或其他HIV相关疾病的可能性。(3)为何一些HIV感染者患病而另一些人不患病,目前尚未完全明确。疾病进展的辅助因素的作用需要进一步研究。可能不存在一个普遍的疾病进展辅助因素,而是有各种导致免疫刺激和潜伏HIV激活的因素。因此,接触多种感染性或环境因素(如通过性传播疾病或注射静脉药物)可能会加速HIV感染者疾病的进展。(4)抗病毒药物是否能预防或降低无症状HIV感染者疾病进展的可能性尚未确定。如果有益,是应该给予所有HIV感染者,还是只给予那些临床和实验室评估显示疾病进展可能性增加的人?鉴于这些不确定性,医生或其他医护人员应如何评估、治疗和咨询HIV感染患者?此类患者应接受全面的医学评估,以进行诊断和分期;这种评估的细节超出了本综述的范围,且已有详细描述。然而,有几点简要内容应予以强调。(摘要截短于250字)